Abstract Scalable, cost-effective manufacturing remains a major barrier to the clinical translation of viral vector–mediated gene therapies. The widely used transfection method for producing adeno-associated virus (AAVs) and lentivirus uses plasmid DNA (pDNA)/polyethyleneimine (PEI) particles loaded with multiple plasmids; however, these particles must be prepared at low concentrations and used immediately, limiting scalability and reproducibility. Here we show a kinetic-gating strategy in which transient binding of trivalent citrate ions slows complexation, modulating charge-neutralization kinetics and delaying particle nucleation, enabling the formation of stable, highly concentrated pDNA/PEI particles. By incorporating citrate, we prevent aggregation and achieve uniform assembly at high concentrations, enabling a ten-fold increase in DNA concentration (to 0.2 mg/mL) and reduced dosing volumes. The method is robust across mixing conditions, compatible with standard manufacturing workflows, and maintains AAV production efficiency across scales. These results establish a simple and generalizable approach to control polyelectrolyte assembly kinetics, improving the scalability and reliability of viral vector production.
Building similarity graph...
Analyzing shared references across papers
Loading...
Jinghan Lin
Johns Hopkins University
Yizong Hu
Johns Hopkins University
Turash H. Pial
Johns Hopkins University
Nature Communications
Building similarity graph...
Analyzing shared references across papers
Loading...
Lin et al. (Tue,) studied this question.
synapsesocial.com/papers/6a2117dfd499ed480b170b86 — DOI: https://doi.org/10.1038/s41467-026-73921-4
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: